| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/29/2009 | US7595062 Orthopedic implant of self-assembled porous structure comprising a collagen type I matrix in its native alpha-helical structure, and a sheet of naturally occurring submucosal matrix secured thereto; sponge as scaffold for tissue repair |
| 09/29/2009 | US7595059 Diagnosis of cysticercosis; immunoassay |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |
| 09/29/2009 | US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 09/29/2009 | US7595053 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
| 09/29/2009 | US7595049 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 09/29/2009 | US7595046 non-small cell lung, colon, colorectal, lymphoma, pancreatic or ovarian cancer |
| 09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
| 09/29/2009 | US7595040 Deamidated interferon-β |
| 09/29/2009 | US7595039 Methods of healing wounds by administering human IL-18 |
| 09/29/2009 | US7595038 Methods of treatment using antibodies to follistatin-3 |
| 09/29/2009 | CA2404163C Production of recombinant blood clotting factors in human cell lines |
| 09/29/2009 | CA2293489C Inhibitors of dna immunostimulatory sequence activity |
| 09/29/2009 | CA2250118C Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/29/2009 | CA2240737C A long qt syndrome gene which encodes kvlqt1 and its association with mink |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/24/2009 | WO2009117640A2 Antibodies against interleukin-10 like cytokines and uses therefor |
| 09/24/2009 | WO2009117513A2 Modified dicer polypeptide and methods of use thereof |
| 09/24/2009 | WO2009117307A2 Viruses lacking epithelial cell receptor entry |
| 09/24/2009 | WO2009117117A1 T cell receptor fusions and conjugates and methods of use there of |
| 09/24/2009 | WO2009117096A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 09/24/2009 | WO2009117035A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/24/2009 | WO2009117004A1 Reagents and methods for use in head and neck cancer diagnosis, classification and therapy |
| 09/24/2009 | WO2009116984A2 Highly thermostable fluorescent proteins |
| 09/24/2009 | WO2009116639A1 Partial peptide of lacritin |
| 09/24/2009 | WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 09/24/2009 | WO2009116524A1 Modified protein |
| 09/24/2009 | WO2009116268A1 Method for quantification of soluble lr11 |
| 09/24/2009 | WO2009115822A1 Nrps-pks gene cluster and its manipulation and utility |
| 09/24/2009 | WO2009115809A2 Thyroid stimulating hormone fusion proteins |
| 09/24/2009 | WO2009115664A2 Crystalline structure of the cc2-lz domain of nemo |
| 09/24/2009 | WO2009115658A2 Use of a caspase-1 inhibitor for treating atherosclerotic plaque |
| 09/24/2009 | WO2009115591A1 Companion diagnostic for cancer |
| 09/24/2009 | WO2009115568A1 Anti-lps factor from parietaria judaica and methods of use thereof |
| 09/24/2009 | WO2009115533A1 Detection of bacterial peptidoglycan-like compounds |
| 09/24/2009 | WO2009115509A2 Antigenic protein fragments of streptococcus pneumoniae |
| 09/24/2009 | WO2009115508A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 09/24/2009 | WO2009115469A1 Protease stabilized, acylated insulin analogues |
| 09/24/2009 | WO2009115212A1 Lxr ligand binding domain (lxr lbd) crystals |
| 09/24/2009 | WO2009114943A1 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 09/24/2009 | WO2009094742A9 Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction |
| 09/24/2009 | WO2009091826A9 Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car) |
| 09/24/2009 | WO2009087082A3 Novel insulin derivatives having an extremely delayed time-action profile |
| 09/24/2009 | WO2009079564A3 Immunogenic compositions and methods of use thereof |
| 09/24/2009 | WO2009079053A3 High affinity metal-oxide binding peptides with reversible binding |
| 09/24/2009 | WO2009077577A3 Vaccine antigens from piscirickettsia salmonis |
| 09/24/2009 | WO2009065912A3 Plants having increased yield-related traits and a method for making the same |
| 09/24/2009 | WO2009061807A3 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 09/24/2009 | WO2009059755A3 Novel neurturin conjugates for pharmaceutical use |
| 09/24/2009 | WO2009058440A3 Lantibiotics from bifidobacterium longum and uses thereof |
| 09/24/2009 | WO2009053041A3 Identification of tumor-associated markers for diagnosis and therapy |
| 09/24/2009 | WO2009044279A3 Peptides having antimicrobial and/or biosurfactant properties |
| 09/24/2009 | WO2009040726A3 Rhamnose antagonists and use thereof |
| 09/24/2009 | WO2009023347A3 Metal resistant plants, and methods of manufacture thereof |
| 09/24/2009 | WO2008143679A9 Nucleic acids and proteins and methods for making and using them |
| 09/24/2009 | WO2002079384A9 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/24/2009 | US20090241226 Gene Encoding Lignan Methylation Enzyme |
| 09/24/2009 | US20090241216 Proteins Involved in After-Cooking Darkening in Potatoes |
| 09/24/2009 | US20090241215 Use of armadillo repeat (arm1) polynucleotides for obtaining pathogen resistance in plants |
| 09/24/2009 | US20090241207 Expression of heterologous genes according to a targeted expression profile |
| 09/24/2009 | US20090241205 Collapsin Response Mediator Protein, CRMP; lacosamide a new analgesic and antiepileptic agent, interacts with CRMP; drug screening, pharmacogenetics |
| 09/24/2009 | US20090241204 Animal model comprising in its genome a homozygous disruption of an endogenous mouse multidrug-resistance-1 (MDR-1) gene ; drug screening; pharmacokinetics and pharmacodynamics; predicting likely behaviour of a drug in mouse |
| 09/24/2009 | US20090240039 Polypeptide fusion |
| 09/24/2009 | US20090240035 Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors |
| 09/24/2009 | US20090240031 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments |
| 09/24/2009 | US20090240029 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 09/24/2009 | US20090240028 Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides |
| 09/24/2009 | US20090239916 Novel drug discovery target and medicine acting on the same |
| 09/24/2009 | US20090239903 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239802 Hsp70 PEPTIDE STIMULATING NATURAL KILLER (NK) CELL ACTIVITY AND USES THEREOF |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239797 Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses |
| 09/24/2009 | US20090239795 exendin-4 fused to a transferrin (Tf) via a polypeptide linker; for treatment of Type II diabetes, obesity, and to reduce body weight |
| 09/24/2009 | US20090239794 Hcv f protein and uses thereof |
| 09/24/2009 | US20090239793 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 09/24/2009 | US20090239790 Novel recombinant proteins with n-terminal free thiol |
| 09/24/2009 | US20090239785 Insulin Derivative |
| 09/24/2009 | US20090239784 Stablised Insulin Compositions |
| 09/24/2009 | US20090239309 Method of stabilizing pulmonary surfactant protein |
| 09/24/2009 | US20090239304 Bioactive peptide for cell adhesion |
| 09/24/2009 | US20090239300 Separating material and method for collecting cell or the like using the same |
| 09/24/2009 | US20090239265 Virus like particles |
| 09/24/2009 | US20090239264 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 09/24/2009 | US20090239262 Affinity Polypeptide for Purification of Recombinant Proteins |
| 09/24/2009 | US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) |
| 09/24/2009 | US20090239260 Fungal Transcriptional Activator Useful In Methods for Producing Polypeptides |
| 09/24/2009 | US20090239240 Mutant Forms of Fas Ligand and Uses Thereof |
| 09/24/2009 | US20090239220 Dlc-1 gene deleted in cancers |
| 09/24/2009 | US20090239219 Telomerase expression repressor proteins and methods of using the same |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238835 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238827 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238819 Therapeutic and diagnostic agents |